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Defects inmitochondrial gene expression are associ-
ated with aging and disease. Mterf proteins have
been implicated in modulating transcription, replica-
tion and protein synthesis. We have solved the
structure of a member of this family, the human mito-
chondrial transcriptional terminator MTERF1, bound
to dsDNA containing the termination sequence. The
structure indicates that upon sequence recognition
MTERF1 unwinds the DNA molecule, promoting
eversion of three nucleotides. Base flipping is critical
for stable binding and transcriptional termination.
Additional structural and biochemical results provide
insight into the DNA binding mechanism and explain
howMTERF1 recognizes its target sequence. Finally,
we have demonstrated that the mitochondrial patho-
genic G3249A and G3244A mutations interfere with
key interactions for sequence recognition, elimi-
nating termination. Our results provide insight into
the role of mterf proteins and suggest a link between
mitochondrial disease and the regulation of mito-
chondrial transcription.
INTRODUCTION
Mitochondrial transcription is responsible for expression of 13
proteins encoded in the mitochondrial DNA as well as synthesis
of two rRNAs and 22 tRNAs (Anderson et al., 1981). Transcription
originates from two promoters located in the regulatory D loop,
a heavy strand and a light strand promoter (HSP and LSP), that
are responsible for transcription of the heavy and light strands,
respectively (Asin-Cayuela and Gustafsson, 2007; Gaspari et al.,
2004; Scarpulla, 2008). Initiation is dependent on the RNA poly-
merase, POLRMT, and two transcription factors, TFAM and
TFB2M (Sologub et al., 2009; Metodiev et al., 2009), while
POLRMT is sufficient for elongation. Hence, mitochondrial tran-
scription can be regulated by modulating the expression of the
genes responsible for the process itself (Scarpulla, 2006; Hock
and Kralli, 2009), but some evidence suggests that transcrip-
tional regulation can occur within the mitochondria as well, for982 Cell 141, 982–993, June 11, 2010 ª2010 Elsevier Inc.instance in response to estrogen (Klinge, 2008). In addition, mito-
chondria contain their own family of dedicated transcriptional
regulators: the mterf proteins. The mterf (for mitochondrial
termination factor) family of proteins contains four members
(MTERF1–4) all of which share homology to MTERF1, a protein
originally identified as a factor responsible for mitochondrial
transcriptional termination. These proteins have been implicated
in mitochondrial transcription, the coordination between tran-
scription and replication and the regulation of mitochondrial
protein synthesis (Linder et al., 2005; Park et al., 2007; Roberti
et al., 2009; Pellegrini et al., 2009). MTERF1 is the canonical
transcriptional terminator and was originally identified as
a factor responsible for terminating heavy strand transcription
at a specific site at the leu-tRNA (Kruse et al., 1989), thereby
modulating the ratio of mitochondrial ribosomal RNA to mRNA
(Roberti et al., 2009). It was later shown that in this context,
besides acting as a termination factor, MTERF1 appears to be
capable of stimulating transcriptional initiation (Martin et al.,
2005). Moreover, it has been proposed that MTERF1 can
mediate the formation of a loop in mitochondrial DNA to promote
efficient rRNA synthesis (Martin et al., 2005), although the ability
of MTERF1 to bind to the HSP region is controversial (Park et al.,
2007). Like other mterf proteins, MTERF1 appears to be multi-
functional, and a recent report has implicated it in the control
of mitochondrial replication pausing (Hyva¨rinen et al., 2007). All
these observations are however based on in vitro experiments,
and no in vivo evidence exists to support any of these proposed
roles. Interestingly, the pathogenic A3243G MELAS mutation
was shown to decrease the ability of MTERF1 to terminate
transcription in vitro (Hess et al., 1991) and yet no obvious tran-
scriptional alterations are observed in cells carrying this MELAS
mutation (Chomyn et al., 1992). A lack of structural information
on this family of proteins has contributed to maintain these
uncertainties about their cellular role. Sequence alignments led
to the suggestion that they are modular leucine-zipper contain-
ing proteins (Fernandez-Silva et al., 1997; Roberti et al., 2006),
and that has been suggested to be the basis of their ability to
bind DNA (Roberti et al., 2009).
In this paper, we have structurally characterized MTERF1
bound to its recognition sequence in the leucine tRNA and
have analyzed its mechanism of binding. Our results unexpect-
edly show that MTERF1 does not bind DNA via leucine-zippers,
but rather promotes transcriptional termination through a novel
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Figure 1. MTERF1 Is a Modular Protein
(A) Amino acid alignment of MTERF1 proteins in
different species. Invariant residues are white
over a black background. Conserved residues
are bold. The numbering corresponds to human
MTERF1. Asterisks indicate residues that stack
with everted nucleotides and dots indicate resi-
dues involved in sequence recognition. Horizontal
black bars represent a helices and dotted lines
represent 310 helices. Hs, Homo sapiens; fc, felis
catus; ss, sus scrofa; ec, equus caballus; bt, bos
taurus; mm, Mus musculus; rn, rattus norvegicus;
oa, ornithorhynchus anatinus; dr, danio rerio.
(B) Overview of the MTERF1 fold. The structure is
shown in the absence of DNA. Mterf motifs are
color coded as in (A).
(C) Overlay of the 8 mterf motifs. The rmsd
between the first (transparent red, ribbon repre-
sentation) and each of the other repeats ranges
between 1.0 and 3.3 A˚ for 24 C-a atoms (the
average is 2.5 A˚). Each repeat is color coded as
in (B).
(D) Hydrophobic interactions stabilize each mterf
repeat. The second mterf motif is shown in ribbon
representation. The hydrophobic residues are
shown in ball-and-stick representation with their
VanderWaals surface in yellow.SeealsoFigureS1.DNA binding mode. Additionally, they provide insight into how
MTERF1 achieves sequence recognition, and provides clues to
understand the biological roles of mterf family proteins. We
have also analyzed a number of pathogenic mitochondrial DNA
mutations for their ability to interfere with MTERF1 binding and
transcriptional termination. We have shown that two mutations,
G3249A that causes a variant of Kearns-Sayre syndrome
(Seneca et al., 2001) and G3242A that is associated with an
uncharacterized mitochondrial disorder (Mimaki et al., 2009),
interfere with protein-DNA interactions that are key for sequence
recognition by MTERF1 and as a consequence eliminate its
transcriptional termination activity.
RESULTS AND DISCUSSION
Structural Determination
In order to investigate howMTERF1 is able to recognize specific
sequences in the mitochondrial genome as well as the mecha-
nism by which it can modulate transcription we decided to
crystallize the full-length human protein (minus the N-terminal
mitochondrial localization sequence; Figure 1A) bound to the
leu-tRNA sequence responsible for termination of transcription
to which MTERF1 binds with high affinity (Nam and Kang,
2005). We expressed and purified human MTERF1 from E. coli
cells and obtained crystals of the protein in complex with a
22-mer double stranded substrate (residues 3232–3253 of the
human mitochondrial DNA). In order to solve the structure taking
advantage of Multiwavelength Anomalous Dispersion phasing
(Hendrickson and Ogata, 1997) we also crystallized MTERF1 in
complex with a double stranded DNA containing eight 5-bromo-
cytosine residues (see Experimental Procedures and Table 1 for
data collection and refinement statistics). The native crystalsdiffracted to 2.2A˚ and contained onemolecule ofMTERF1 bound
to DNA in the asymmetric unit. The final density was of sufficient
quality to build most of the protein (residues 73 to 396; Figure 1
and Figure S1 available online) and all 22 base pairs of DNA.
Overall Structure
MTERF1 adopts a fold that is very different from previously
proposed models (Fernandez-Silva et al., 1997; Figure 1B).
Consistent with predictions based on its primary sequence
(Fernandez-Silva et al., 1997; Roberti et al., 2006), MTERF1
displays a modular architecture. Dali (Holm et al., 2008) and De-
jaVu (Kleywegt and Jones, 1997) were unable to identify signifi-
cant structural homology with any protein in the PDB. MTERF1
is an all-a-helical protein composed of 19 a helices and 7 310
helices that is structured around a motif (two a helices followed
by a 310 helix; hence referred to as the mterf motif) that is
repeated throughout the structure (Figure 1B). This structural
arrangement is remarkably similar to that seen in other all-alpha
helical regions of proteins such as repeats of armadillo (ARM),
HEAT (Groves and Barford, 1999) and PUM/PUF motifs (Lu
et al., 2009). In all these cases the protein fold consists of
a number of repeats of more or less conserved a-helical motifs.
Interestingly, PUM/PUF motifs are the basis of RNA binding in
PUMILIO proteins (Lu et al., 2009) while the HEAT motifs in
DNA PK-cs have been suggested to play a role in double
stranded DNA binding (Sibanda et al., 2010).
The MTERF1 fold contains 8 mterf motifs and an additional
distorted motif in the C terminus (Figure 1C). Within each motif,
several hydrophobic residues create a hydrophobic core
between the two a helices (Figure 1D). The abundance of hydro-
phobic residues is whatmakes the primary sequence ofMTERF1
similar to a leucine-zipper protein, but no association could beCell 141, 982–993, June 11, 2010 ª2010 Elsevier Inc. 983
Table 1. Data Collection, Phasing, and Refinement Statistics
WT Native WT 5BrdC Triple mutant
PDB code 3MVA 3MVB
Data collection
Space group c2221 c2221 c2221
Cell dimensions (A˚) 88.63, 89.71, 161.29 88.49, 89.93, 162.13 87.53, 91.43, 159.05
a, b, g () 90, 90, 90 90, 90, 90 90, 90, 90
Peak Inflection Remote
Wavelength 1.0750 0.9195 0.9197 0.9000 1.0750
Resolution (A˚) 2.20 2.80 2.90 2.80 2.80
Rsym 5.0 (60.2) 9.8 (70.7) 9.9 (76.9) 7.7 (50.6) 9.1 (66.1)
I/sI 53.4 (2.7) 30.8 (3.6) 28.8 (3.6) 37.0 (4.5) 22.0 (2.7)
Completeness (%) 99.2 (99.1) 99.6 (100) 99.9 (100) 99.9 (100) 99.4 (99.1)
Redundancy 7.2 7.4 7.4 7.6 5.8
Refinement
Resolution (A˚) 2.20 2.80
Unique reflections 32806 16183
Rwork/Rfree 20.5/24.4 20.3/26.5
No. atoms 3620 3522
Protein 2606 2588
DNA 896 896
Water 118 38
Mean B-factors 66.5 41.2
Protein 65.9 42.1
DNA 68.7 38.8
Water 62.3 33.7
Rmsds
Bond lengths (A˚) 0.006 0.007
Bond angles () 1.24 1.27
Values in parenthesis are for the highest resolution shell.found between the predicted motifs (Fernandez-Silva et al.,
1997; Roberti et al., 2006) and any differential structural feature.
Hydrophobic interactions are also frequently observed between
mterf motifs, but are far less abundant. This suggests a certain
rigidity of the individual motifs but relative flexibility between
motifs and thus of the overall fold.
DNA Binding and Unwinding
MTERF1 binds to the double-stranded substrate containing the
termination sequence (Figure S2) as a monomer and adopts
a binding mode resulting in a remarkably large footprint on the
DNA molecule. MTERF1 covers twenty base pairs even though
binding does not strongly alter the curvature of the DNA duplex
(Figures 2A and 2B). Taking advantage of its specialized archi-
tecture, MTERF1 binds along the major groove of DNA. DNA
binding by MTERF1 imposes a slight bend (25) in the DNA
duplex (Figure 2C). More importantly, while the ends of the
DNA duplex remain in a mostly B-DNA conformation, the DNA
structure of the central part of the recognition sequence is
heavily distorted. Binding by MTERF1 appears to decrease the
twist of the DNA duplex, resulting in significant DNA unwinding
(Figure 2D). Moreover, MTERF1 binding promotes partial duplex984 Cell 141, 982–993, June 11, 2010 ª2010 Elsevier Inc.melting: the central part of the DNA contains three nucleotides
that are everted from the double-helix (Figure 2E).
Base Flipping
Each of the nucleotides everted from the double-helix is stabi-
lized by the protein via a stacking interaction (Figure 2F) and
by hydrogen bonds to the base and phosphate (Figure 3A). In
order to investigate this point, we constructed and purified
a triple R162A/F243A/Y288A mutant in which all stacking inter-
actions that presumably stabilize the conformation observed in
the structure would be eliminated. We decided to crystallize
this mutant in complex with the termination sequence. We
obtained crystals that diffracted to 2.8A˚ (see Table 1) and were
able to solve the structure by molecular replacement using the
WT MTERF1 structure as a model (see Experimental Proce-
dures). Inspection of the structure showed that the triple mutant
is folded exactly asWTMTERF1 (rmsdof 0.6A˚ for 324C-a atoms;
Figure 3B). Importantly, the protein is bound to the termination
sequence in an identical manner as the WT protein: the DNA
backbone in the mutant structure presents the same bend
observed in the WT structure and the double-helix is equally
unwound. However, removal of the stacking interactions altered
Figure 2. A Unique DNA Binding Mode
(A) Global view of the protein-DNA interaction.
Each repeatedmterf motif is colored as in Figure 1.
The light strand is brown and the heavy strand is
gray. The molecular surface is rendered trans-
parent.
(B) A 90 rotation of the view in (A).
(C) MTERF1 induces a 25 bend in the DNA mole-
cule. The light strand is green and the heavy strand
is yellow.
(D) MTERF1 unwinds the DNA double-helix. Over-
lay between the DNA observed in the crystal struc-
ture (the heavy and light strands are green and
yellow, respectively) and ideal B-form DNA
(magenta and blue). The ends of the DNAmolecule
adopt B conformation (black bars). The central
part of the molecule (black arrows) is unwound.
(E) Three nucleotides (yellow in the figure; corre-
sponding to A3243 of the light strand and T3243
and C3242 of the heavy strand) are everted from
the double-helix in the central part of the structure.
A simulated annealing fo-fc electron density map
is shown contoured at 3s.
(F) The three everted nucleotides are stabilized by
p-stacking interactions. R162 (orange), F234
(magenta) and Y288 (red) stack against each of
the everted nucleotides (color coded as in [B]).
The light strand is green and the heavy strand
yellow.the conformation of all three everted nucleotides (Figure 3C).
Two of them, the adenine and thymine (green and blue in
Figure 2F) are now flipped back into the double helix. A third
one, the cytosine (yellow in Figure 2F), while not in the same
conformation as in the WT structure, is still everted from the
double helix. It is now occupying the position that the Arg162
side chain occupies in the WT structure. The cytosine base
appears to be stabilized by contacts to protein backbone atoms
but, unlike in the WT structure, it does not take advantage of p-p
stacking interactions and therefore this conformation does not
appear as favorable.
These observations demonstrate that stacking interactions
are essential to stabilize the everted nucleotides and that the
protein is actively promoting base-flipping. Furthermore, the
fact that backbone distortion and unwinding is still present in
the mutant structure indicates that MTERF1 binding by itselfCell 141, 982–9(at least in a sequence-specific context)
unwinds and kinks the DNA duplex. This
backbone distortion is independent of
base-flipping, although by destabilizing
the central base pairs it is likely essential
to facilitate it. It is interesting to note
that Arg162 is the only one of the
three stacking residues that is universally
conserved in MTERF1 proteins (Fig-
ure 1A). This suggests that differences
must exist in the wayMTERF1 associates
with DNA in some of these species. It
also perhaps suggests that the role ofthe three stacking residues in promoting base-flipping is not
equivalent.
DNABackbone Interactions andUnspecific DNABinding
MTERF1 establishes numerous interactions with the DNA
duplex. The backbone of both strands is bound along positively
charged grooves in the protein surface (Figure 3D). Most of
the interactions that are observed in the structure are elec-
trostatic in nature and are established with the phosphate
groups of the DNA strands (Figure 3A). This type of interaction
does not impart any sequence specificity. Each of the mterf
motifs contributes DNA backbone interactions. The interac-
tions with the light strand appear to be much more numerous
(Figure 3A), consistent with the reported stronger affinity of
the protein for the mitochondrial light strand (Nam and Kang,
2005).93, June 11, 2010 ª2010 Elsevier Inc. 985
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Figure 3. Interactions of MTERF1 with DNA
(A) Scheme of the interactions between MTERF1
and the double-stranded DNA. Each interaction
is listed with an arrow pointing either to the
phosphate or to a DNA base. The three everted
nucleotides and the residues that stack with
them are colored. The five arginine residues that
determine sequence specificity are shown in
blue. W indicates a water mediated interaction.
(B) Overlay of C-a traces of WT (yellow) and triple
mutant (magenta) structures. The DNA backbone
is also shown for each of the DNA strands. The
WT light and heavy strands are colored red and
orange, respectively. The mutant DNA strands
are colored green (light) and blue (heavy).
(C) Overlay of the central part of the DNA duplex in
the WT and mutant structures. The three nucleo-
tides that are everted in the WT structure are
shown. The mutant heavy strand is blue, while
the light strand is green. A simulated-annealing
fo-fc omit electron density map is shown, con-
toured at 3s. The DNA in theWT structure is shown
as a reference. The WT heavy strand is shown in
brown while the light strand is magenta. Black
arrows indicate the changes in the position of the
everted nucleotides that are observed upon muta-
tion of the three stacking residues.
(D) Electrostatic surface potential of MTERF1.
The protein surface is shown, colored between
10 kT e1 (red) and 10 kT e1 (blue). The DNA
backbone is shown in yellow (light strand) and
green (heavy strand).
(E) Sequence recognition by arginine residues. Five arginine residues determine sequence recognition byMTERF1. A representative example showing how R169
and R202 interact with their partner guanine residues. The R202 interaction is atypical in that only one hydrogen bond is established with the guanine base.
Hydrogen-bonding distances are shown in orange. A simulated annealing fo-fc electron density map is shown contoured at 4s. See also Figure S2.The number of sequence-independent interactions suggested
that MTERF1 should be able to bind double stranded DNA
regardless of sequence. To investigate this point, we performed
isothermal titration calorimetry (ITC) experiments. As expected,
MTERF1 was able to bind to its specific recognition sequence
and did so with near 1:1 stoichiometry (Figure 4A and Figure 4D),
further indicating specific binding. Binding was significantly
affected by the salt concentration, consistent with the number
of protein-DNA electrostatic interactions. Because of the
tendency of the protein to aggregate at lower salt concentrations
in the absence of DNA we performed all subsequent experi-
ments at 200 mM KCl, even though at this salt concentration
MTERF1 exhibits weaker binding (see Experimental Procedures
and Figure 4D). Our measurements also demonstrate that
MTERF1 is capable of binding a double stranded DNA of arbi-
trary sequence, although with significantly lower affinity than
for its specific recognition sequence (Figure 4D and Figure S3A).
Importantly, the lower DNA to protein ratio of binding indicates
that MTERF1 does not preferentially associate with the DNA
duplex in a particular conformation, consistent with the lack of
sequence specificity. Instead, it can bind to different regions of
the duplex and as a consequence more than one MTERF1 mole-
cule can simultaneously bind the same substrate molecule. To
eliminate the possibility that accidental sequence similarity
with the WT sequence could result in residual specific binding
and affect the measurements, we repeated them with two addi-986 Cell 141, 982–993, June 11, 2010 ª2010 Elsevier Inc.tional substrates: a homopolymeric DNA (Figure S3C) and
a completely random sequence (not shown). The results led in
both cases to identical conclusions (Figure 4D).
Nucleotide Eversion Is Essential for Stable DNA Binding
The difference in binding affinity between unspecific and
specific binding can be rationalized from the crystal structure.
In a sequence-specific context as observed in the structure,
MTERF1 binds DNA in a distorted conformation, where each of
the three nucleotides everted from the double-helix is stabilized
by the protein via a stacking interaction (Figure 2F) and, in addi-
tion, by hydrogen bonds to the base and phosphate (Figure 3A).
It was therefore tempting to speculate that while MTERF1 can
bind to any double stranded DNA molecule by virtue of its elec-
trostatic surface, the distorted conformation observed in the
crystal structure is only adopted upon recognition of a specific
sequence and is responsible for stable specific binding. In order
to investigate this, we performed DNA binding measurements
using the triple R162A/F243A/Y288A mutant to analyze its ability
to bind to the termination sequence. As expected from the struc-
ture, the affinity for DNA of the triple mutant is significantly
reduced (Figures 4B and 4D) and is similar to that of WTMTERF1
for an unspecific DNA sequence (Figure 4D), indicating that
nucleotide eversion is essential for stable binding. Furthermore,
the triple mutation does not seem to affect binding to the oligo-
nucleotide of arbitrary sequence in a significant way (Figure 4D
A B C
D
Figure 4. DNA Binding Measurements
ITC data from the titration of the leu-tRNA MTERF1
binding sequence into WT MTERF1 (A), the triple
R162A-F243A-Y288A mutant (B) or the R387A mutant
(C). (D) Summary of the observed binding constants.
The sequence of each substrate (one of the strands) is
indicated at the top of the table. See also Figure S3.and Figure S3B), strongly supporting the idea that base eversion
is only a feature of sequence-specific binding. Importantly, since
the triple mutant structure indicates that bending and unwinding
of the DNA still take place, the increase in affinity can be entirely
attributed to the ability of the enzyme to promote base-flipping.
Mechanism of Sequence Recognition
The observed binding stoichiometry when titrating the triple
mutant (Figure 4D) implies that despite lower binding affinity
the mutant still conserves site-specificity (i.e., the stoichiometry
is still close to 1). Moreover, the structure indicates that it binds
DNA just like the WT protein. This is also consistent with the
fact that the stacking residues would appear to contribute little
to sequence recognition. Because most of the protein-DNA
interactions observed in the structure are to the DNA backbone,
there are only a handful of interactions that appear capable of
discriminating against a particular sequence. Sequence recogni-
tion thus seems to be mediated by specific hydrogen bonding
to the DNA major groove. Five arginine residues (blue in
Figure 3A) establish base interactions that are likely to deter-
mine sequence-specificity. Three of these (Arg 169, Arg350 andCell 141, 9Arg387) simultaneously hydrogen-bond to N7
and O6 of a guanine base (Figure 3E). Arg202
hydrogen bonds to two adjacent guanines in
opposite strands (Figure 3E), while Arg 251
hydrogen bonds to O6 of a single guanine
and to N7 of the adjacent adenine. These argi-
nine residues (black dots in Figure 1A) are
conserved in MTERF1, as are the nucleotides
that they recognize in the mitochondrial
DNA (Figure S2). Interestingly, these arginines
are not conserved in other mterf proteins
(Figure S1), consistent with their different
sequence specificity.
To assess the role of these residues in
determining sequence specificity, we decided
to construct individual arginine to alanine
substitutions. ITC measurements (Figure 4D)
allowed us to conclude that these residues
play a role in sequence recognition. Interest-
ingly, only R387A appears to have completely
lost specific binding (Figures 4C and 4D). All
other mutants appear to preserve some
sequence specificity but, with the possible
exception of R350A, they all show lower
binding affinity for the termination sequence
than the WT protein. This suggests that
some of these residues might play an impor-
tant role in determining the conformationsobserved in the crystal structure, and also indicates that the
importance of each of these residues for DNA binding and
sequence recognition is not equal, prompting us to analyze their
ability to promote transcriptional termination.
Implications for Transcriptional Termination
To analyze the functional importance of the different protein-
DNA interactions we studied the ability of the different proteins
to promote transcriptional termination in a reconstituted
in vitro system. We adapted the assay utilized by Asin-Cayuela
and colleagues (Asin-Cayuela et al., 2005) and generated
a substrate for run-off transcription from the HSP where the
termination sequence (the 22-mer sequence used for crystalliza-
tion) has been inserted 100 bp downstream from the promoter
(see Experimental Procedures). As can be seen in Figure 5A,
TFAM, TFB2M, and POLRMT generate a unique run-off tran-
scription product on this substrate, but addition of MTERF1
results in appearance of a specific termination product. Our
results are essentially equivalent to previously published data
(Asin-Cayuela et al., 2005), suggesting that our purified MTERF1
is active and confirming that, at least in vitro, MTERF1 only82–993, June 11, 2010 ª2010 Elsevier Inc. 987
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E Figure 5. Termination Activity of WT and
Mutant MTERF1
(A) In vitro termination activity. WT MTERF1 and
the different mutants were assayed for their ability
to terminate transcription from the HSP promoter
in vitro (see Experimental Procedures). The termi-
nation sequence was cloned in either the forward
(A) or reverse orientation (B). The results are equiv-
alent on both orientations and show clear termina-
tion for WT MTERF1 but only residual termination
for the triple (RFY) mutant and theR387Amutation.
FL, full-length run-off transcription. T, termination
product. C, control lane without MTERF1. (C)
Quantification of the termination activity. The bar
graph shows the percent termination observed in
in vitro termination experiments with the termina-
tion sequence in the reverse orientation. Values
correspond to themean ±SDof at least three inde-
pendent experiments. (D) Termination activity of
the remaining arginine mutants. E. Model depict-
ing the events leading to specific DNA binding by
MTERF1 (represented as a yellow oval).displays moderate termination activity. It has however been
previously shown that the termination activity of MTERF1 is
substantially stronger when the termination sequence is inverted
as to simulate termination of LSP-initiated transcription (Asin-
Cayuela et al., 2005). We decided to analyze transcriptional
termination in this orientation as well. As can be seen in
Figure 5B, termination in this orientation is indeed much more
robust, perhaps in agreement with the observed pattern of inter-
actions and the stronger affinity of MTERF1 for the light strand
(Nam and Kang, 2005). In contrast, as expected from the binding
data, no termination was observed with the triple mutant even
when a substantial excess of protein was added to the reaction
(Figure 5A/B, RFY). Unexpectedly, none of the five arginine
mutants were able to promote termination (Figure 5A, Fig-
ure 5B, and Figure 5D). The higher signal observed in the reverse
orientation allowed us to quantify the termination activity. The
results (Figure 5C) indicate that while WT MTERF1 achieved
an average of near 75% termination over the course of a twenty
minute reaction, the triple mutant only supported residual
termination (<5%). The arginine mutations, irrespective of DNA
binding affinity, were equally unable to support termination
(<5%), with only some termination activity observed for R350A
(17.7%).
This supports the functional importance of the main interac-
tions suggested by the crystal structure. Since the triplemutation
solely affects nucleotide eversion, our data clearly demonstrate
the critical importance of base-flipping for transcriptional termi-
nation. They also indicate that while there is a correlation
between DNA binding affinity and termination activity, the role
of some residues appear to be more important for termination
than for binding. Because all arginine-guanine interactions
appear to be essentially equivalent, this suggests that, beyond988 Cell 141, 982–993, June 11, 2010 ª2010 Elsevier Inc.the importance of the interaction itself, some or all of these
residues might also be essential to enable the conformation
observed in the WT structure. Additional studies will be needed
to establish their individual roles.
A Model for DNA Binding
Based on our results, we can recapitulate the events leading to
specific MTERF1 binding and propose a model for how this
protein promotes transcriptional termination. We have shown
thatMTERF1 is able to interact with DNA in a sequence-indepen-
dent manner, suggesting that the protein probes the mitochon-
drial DNA randomly in search of its recognition sequence.
Several of our observations suggest that unspecific DNA binding
is likely to be structurally different from specific binding. Our data
demonstrate that base-flipping determines the higher binding
affinity observed for the specific termination sequence. This
strongly suggests that base-flipping does not take place when
binding to an unspecific sequence. Moreover, the stacking inter-
actions that stabilize base-flipping do not appear to be respon-
sible to discriminate against unspecific sequences. Thus the
WT protein would be likely to promote base-flipping regardless
of sequence if the DNA duplex was destabilized as in the WT
structure. This would imply that sequence-unspecific binding is
unlikely to lead to the DNA conformation observed in the WT
structure, suggesting a need for MTERF1 to adopt different
conformations. Finally, our termination results suggest that the
five arginine residues involved in sequence recognition might
play an important role in determining these events. We therefore
propose a model for MTERF1 binding (Figure 5E) wherein
binding to the correct sequence results in the six key arginine-
guanine interactions being established (perhaps sequentially),
which leads to a concurrent protein conformational change
that bends and unwinds the DNA duplex. This in turn promotes
the unstacking of three nucleotides, which are then stabilized
in an extrahelical conformation by three stacking interactions.
Our results indicate that base-flipping is essential for stable
binding, suggesting that MTERF1 takes advantage of this mech-
anism to increase the stability of its interaction with DNA. Since
we have shown that base-flipping is essential to promote tran-
scriptional termination, this suggests that this activity is simply
related to the ability of MTERF1 to successfully prevent the
RNA polymerase from displacing it from the termination
sequence. Similarly, acting as a temporary roadblock might be
the mechanism by which MTERF1 participates in controlling
mitochondrial replication.
Pathogenic Mutations in the leu-tRNA
Our structures allow us to precisely determine which nucleotides
of the mitochondrial DNA are contacting MTERF1 while binding
to its termination sequence. In addition, themechanism bywhich
MTERF1 recognizes its binding sequence implies that the iden-
tity of bases far away from the center of the target sequence
are critical for sequence recognition. Based on these observa-
tions, we surveyed a collection of pathogenic mitochondrial
DNA mutations that occur in the MTERF1 binding sequence of
the leu-tRNA and examined their potential to interfere with
binding and transcriptional termination. Nine mutations (two of
them on the same nucleotide; Figure 6A) fall in the sequence
recognized by MTERF1. It is important to note that the patho-
genic effects of these mutations might be simply due to an alter-
ation on the leu-tRNA structure, and this appears indeed to be
the case for the A3243G mutation (Sasarman et al., 2008).
A3243G is frequently identified in MELAS patients and has
been previously shown to slightly reduce MTERF1 binding
(Hess et al., 1991) and proposed to interfere in vitro with tran-
scriptional termination (Hess et al., 1991; Chomyn et al., 1992).
We can understand these effects based on the crystal structure.
A3243 is one of the three everted nucleotides (Figure 3A) and
a transition mutation would maintain the basic structure of the
purine ring, likely allowing the same conformation observed
with theWT termination sequence. However, themutation would
substitute an A:T base pair by a stronger G:C base pair, which
might explain the slight decrease in binding. In addition, the O6
of the guanine base would be located in close proximity of
a phosphate oxygen (O2P in A3242), perhaps contributing to
destabilization of the WT conformation. Our measurements
confirm that A3243G results in slightly decreased binding
(Figure 6A and Figure S3E). A similar binding affinity was
observed for the A3243T mutation (Figure 6A). In this case the
A:T base pair is preserved, but the larger purine ring is now
located in the heavy strand, which would likely lead to a steric
clash with Asn199 (Figure 3A). All remaining mutations would
not be expected to severely conflict with MTERF1 sequence
recognition, except for G3242A and G3249A. G3242 interacts
in the structure with Arg251, while G3249 forms a double
hydrogen bond with Arg387 (Figure 6B). Both of these mutations
would eliminate a guanine-arginine interaction: the hydrogen
bond between O6 of the guanine and the amino group of the
arginine could not be formed in the mutant DNA. Consistent
with the mild decrease in binding observed in the R251Amutant,G3242A resulted in weak or no effect on binding. However, the
G3249A mutation appears to completely eliminate specific
DNA binding (Figure 6A and Figure S3E), consistent with the
effect of the R387A mutation.
To further analyze the functional consequences of these mito-
chondrial DNA mutations, we carried out termination assays
using both the forward and reverse orientations of the termina-
tion sequence. The results (Figures 6C and 6D) are mostly
consistent with the DNA binding data. As expected, only residual
termination is observed in both orientations with the G3249A
mutation. In addition, consistent with what was observed with
the R251A mutant, the G3242A mutation, while not substantially
altering binding, results nevertheless in a strong decrease in
termination. The A3243G mutation moderately reduces termina-
tion, while termination on A3243T is only marginally weaker than
for the WT sequence. The reduction in termination observed for
A3243G is consistent with what was previously reported (Hess
et al., 1991). Unexpectedly, one additional mutation appears to
moderately affect termination: G3244A, while not affecting
DNA binding, results in a moderate but reproducible effect on
termination. Interestingly, no specific interaction is observed in
the crystal structure with any of the nucleotides in this base
pair. However, it is adjacent to the extrahelical A:T base pair
and displays a high base pair buckle (see Experimental Proce-
dures). It is possible that the strength of the G:C base pair in
the WT sequence is important to maintain this conformation
and that the G3244A mutation thus leads to a slight destabiliza-
tion of the bound MTERF1 that is sufficient to make it more
readily displaced by the RNA polymerase.
CONCLUSIONS
Wehave reported the structure of humanMTERF1. Our structure
suggests that the mterf proteins constitute a family of dedicated
DNA binding proteins, as can be readily concluded from inspec-
tion of the protein fold and the relatively high conservation
between family members (Figure 1S). In addition, our results
suggest a unique mechanism of sequence recognition and
binding where sequence-independent binding is followed by
sequence recognition, resulting in a conformational change
leading to unwinding of the DNA double-helix and base flipping.
Base flipping appears to be critical to confer on MTERF1 the
ability to stably bind to a specific site in DNA. Stable DNA
binding, in turn, is necessary for the ability of this protein to
promote transcriptional termination. Since base flipping does
not affect the conformation of the DNA duplex, our results
suggest that MTERF1 promotes termination by interfering with
the elongation machinery. In this respect it is interesting to stress
that, as was previously observed (Asin-Cayuela et al., 2005),
MTERF1 appears to be much more efficient at promoting termi-
nation from the LSP than from the HSP. This might reflect the
need to prevent transcription from the LSP from interfering
with rRNA synthesis, and is consistent with the stronger affinity
for the light strand (Nam and Kang, 2005) and the large number
of interactions established with this strand. While our structure
does not address if or how MTERF1 can form the MtDNA loop
implicated in rRNA synthesis, the extensive protein-DNA interac-
tion surface observed in the structure indicates that MTERF1Cell 141, 982–993, June 11, 2010 ª2010 Elsevier Inc. 989
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Figure 6. Pathogenic DNA Mutations in the Mitochondrial Termination Sequence
(A) Scheme indicating the location of the mutations in the termination sequence and binding constants for titrations of a 22 bp oligonucleotide containing the
leu-tRNA MTERF1 binding sequence carrying each of the pathogenic mutations into WT MTERF1. The DNA residues involved in arginine guanine interactions
with MTERF1 are indicated by an asterisk.
(B) Interaction of R387 with G3249. Hydrogen-bonding distances are shown in orange. A simulated annealing fo-fc electron density map is shown (blue)
contoured at 4s.
(C) In vitro termination activity of WTMTERF1 on substrates containing each of the nine pathogenic mutations. FL, full-length run-off transcription. T, termination
product. C, control lane without MTERF1.
(D) Quantification of termination activity on the different mutant sequences. The bar graph shows the percent termination observed in in vitro termination exper-
iments with the termination sequence in the reverse orientation. Values correspond to the mean ± SD of at least three independent experiments.would not be able to simultaneously associate with two DNA
duplexes. This therefore implies that it is unlikely that the loop
can be mediated by a single MTERF1 molecule. On the other
hand, the partial duplex melting observed in the structure,
together with the preferential binding to the light strand and rela-
tively low number of interactions with the heavy strand, suggest990 Cell 141, 982–993, June 11, 2010 ª2010 Elsevier Inc.a mechanism by which MTERF1 or other mterf proteins could
facilitate transcriptional initiation by contributing to initial duplex
melting. In this respect it is important to note that Phe243
appears to be conserved in MTERF2 and MTERF3 (Linder
et al., 2005; Figure 1S), and that MTERF2 has been suggested
to positively regulate transcriptional initiation (Wenz et al.,
2009). Finally, it is easy to imagine how this binding fold can be
utilized to recognize different sequences given that only five gua-
nine residues appear to be essential for sequence recognition.
An entirely different specificity could perhaps be obtained by
alteration of the handful of residues responsible for sequence
recognition. In this respect, it is interesting to note that both
the modular architecture of MTERF1 and its sequence recogni-
tion mechanism are highly reminiscent of the PUF family of
RNA binding proteins, where recognition of individual bases
can be modulated by mutation of residues at key positions
(Lu et al., 2009). These similarities also perhaps suggest that
the mterf fold is not necessarily restricted to binding double
stranded DNA.
Base flipping is a key feature of the interaction of MTERF1 with
DNA. Base-flipping was identified as a mechanism used by HhaI
methyltransferase to access its substrate (Klimasauskas et al.,
1994). Since then, a large number of base-flipping enzymes
have been identified that take advantage of this mechanism
(Reinisch et al., 1995; Roberts and Cheng, 1998; Huffman
et al., 2005). It is commonly employed by different DNA repair
and replication proteins that require access to a specific base
in the DNA duplex (Huffman et al., 2005). Because nucleotide
eversion is not energetically favorable, in these proteins, as in
MTERF1, the everted base is usually stabilized by p-stacking
interactions. Base-flipping is usually utilized either to help recog-
nize specific features of the DNA molecule or to assist in the
catalytic mechanism, usually to gain access to a substrate that
is otherwise buried in the DNA double-helix. In this case, base-
flipping appears to be employed solely to stabilize the protein
on DNA and make it more difficult to be displaced. The fact
that this mechanism can be successfully utilized for a completely
different purpose further illustrates the frequent recycling of
structural motifs and solutions that has occurred throughout
evolution.
An important conclusion derived from the crystal structure is
that two pathogenic mutations that interfere with arginine-
guanine interactions involved in sequence recognition by
MTERF1 result in a strong impairment in the ability of MTERF1
to terminate transcription. G3242A does not substantially affect
binding, but very strongly reduces the ability ofMTERF1 to termi-
nate transcription, while G3249A appears to completely elimi-
nate specific binding by MTERF1 and consequently severely
impairs termination. Their strong effect on termination suggests
that the pathogenic effects of the G3249A and G3242A MtDNA
mutations might be at least partially mediated by interfering
with the activity of MTERF1 at the leu-tRNA site. The G3249A
mutation leads to the development of a variant of Kearns-Sayre
syndrome (Seneca et al., 2001), a mitochondrial myopathy, while
the G3242A mutation has been associated with an uncharacter-
ized mitochondrial disorder (Mimaki et al., 2009). It has been
previously suggested that transcriptional deregulation might be
one of the mechanisms leading to mitochondrial dysfunction.
This is consistent with the fact that mice deficient in MTERF2
develop features of mitochondrial myopathies (Wenz et al.,
2009). Further experiments will be needed to address whether
the G3249A and G3242Amutations result in transcriptional alter-
ations in vivo and if this effect is sufficient to explain their clinical
phenotype.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
WT MTERF1 (residues 57–399), TFB2M and POLRMT (a generous gift of
C. Gustafsson) were cloned into pTEV-HMBP3, allowing expression of a fusion
with his-tagged maltose binding protein (MBP) cleavable by TEV protease. The
triple R162A-F243A-Y288A mutant and each of the five arginine mutants were
constructed by QuikChange mutagenesis (Stratagene). His-tagged TFAM was
cloned in pET-22. Proteins were overexpressed in Arctic Xpress E.coli (DE3)
cells (Stratagene) at 16C for 20 hr. WT and mutant MTERF1 proteins and
TFB2M were purified using ProBond Resin (Invitrogen), followed by overnight
TEV protease cleavage, Heparin and Mono S chromatography. POLRMT was
purified byHeparin chromatography, overnight TEV protease cleavage, second
HeparinandMonoSchromatography.TFAMwaspurifiedusingProBondResin,
Heparin and Mono S chromatography. Proteins were concentrated using
a 10,000 MWCO Amicon Ultra-15 device. Concentrated proteins were stored
in 20 mM HEPES (pH 8.0), 200 mM KCl, 5% glycerol, and 1mM DTT.
Crystallization and Structure Determination
Natural and 5Br-dC 22-mer oligonucleotides were synthesized, annealed and
combined with the protein in a 2:1 ratio. Crystals grew at room temperature in
100 mM Bis-Tris, pH 5.0-6.0, 18%–21% PEG 3350, 200 mM potassium
sodium tartrate. Data collection was performed at beamlines X25 and X29 at
the National Synchrotron Light Source (BNL). Both datasets were processed
using HKL2000 (Otwinowski and Minor, 1997; Table 1). The WT structure
was determined by Multiwavelength Anomalous Diffraction (Hendrickson
and Ogata, 1997) using three datasets. Heavy atom sites were located
with Shelx (Sheldrick, 1990). Subsequent refinement and phase calculation
to 3.6 A˚ were performed using SHARP (Fortelle and Bricogne, 1997). Density
modification and phase extension were performed using DM (Cowtan,
1994), and model building with Coot (Emsley and Cowtan, 2004). The resulting
model was refined against the native data set using Phenix (Terwilliger, 2002).
The model includes all nucleotides and residues 73–396 of MTERF1. Model
quality was assessed using MOLPROBITY (Davis et al., 2007). The mutant
structure was solved by molecular replacement using molrep (Vagin and
Teplyakov, 1997). Analyses of the helical parameters of the DNA molecule
were carried out using Curves+ (Lavery et al., 2009).
Binding Measurements
ITC experiments were performed with a VP-ITC calorimeter (Microcal) at
4C. WT or mutant MTERF1 (20-25 mM) was titrated with 10 ml injections of
200–250 mM 22 bp oligonucleotide pairs. Samples were prepared by dialyzing
all interacting components against a buffer containing 20 mM HEPES, pH 8.0,
200 mM KCl, 2.5% glycerol, 1 mM EDTA. Data were analyzed using the
ORIGIN software.
Transcriptional Termination
Assays were adapted from Asin-Cayuela et al., 2005. Nucleotides 491–790 of
the human mitochondrial DNA (containing the HSP) were cloned between the
NcoI and HindIII sites of pET-22 (Novagen), and the termination sequence was
inserted 100 bp from the initiation site in both orientations by site directed
mutagenesis. Additional mutations were carried out by site directed mutagen-
esis. The substrate was linearized using HindIII. Reactions were carried out in
20 ml and contained 30 ng DNA, 20 mM HEPES, (pH 8.0), 5% glycerol, 10 mM
MgCl2, 150 mM KCl, 1 mM DTT, 100 mg/ml BSA, 0.4 mM ATP, 0.15 mM CTP
andGTP, 0.01mMUTP and 1 ml of [a-32P]UTP. 1.5, 3 or 6 pmol ofWT ormutant
MTERF1 was added and the mixture incubated for 30 min at RT. Transcription
was initiated by addition of 400 fmol POLRMT, 500 fmol TFB2M and 2.5 pmol
TFAM. Reactions were incubated for 30 min at 32C and stopped by adding
100 ml of 1% SDS, 20 mM EDTA, 300 mM NaAc, 20 mg Calf Thymus DNA
and 0.12 mg/ml glycogen. Products were phenol extracted, ethanol precipi-
tated, resuspended in 20 ml of loading buffer and analyzed by PAGE.
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